Published in Exp Hematol on September 01, 1987
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol (1998) 2.55
Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II. Science (1986) 1.91
Genetic screening: marvel or menace? Science (1984) 1.78
Transcription during bacteriophage SPO1 development: mutations affecting the program of viral transcription. J Mol Biol (1971) 1.52
Genetic counseling for beta-thalassemia trait following health screening in a health maintenance organization: comparison of programmed and conventional counseling. Am J Hum Genet (1981) 1.44
Diffusion and imaging properties of three new lipophilic tracers, NeuroVue Maroon, NeuroVue Red and NeuroVue Green and their use for double and triple labeling of neuronal profile. Brain Res Bull (2005) 1.44
Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: effects on knowledge and mood. Am J Hum Genet (1979) 1.39
Women's receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health (1995) 1.35
Newborn screening for hemoglobinopathies in New York State: experience of physicians and parents of affected children. J Pediatr (1982) 1.35
Prenatal screening for hemoglobinopathies. II. Evaluation of counseling. Am J Hum Genet (1991) 1.13
Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: comparison of three counseling methods. Am J Hum Genet (1984) 1.13
Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: loss of heterozygosity for chromosome 17. Genes Chromosomes Cancer (1989) 1.13
Anhidrotic ectodermal dysplasia: predisposition to bronchial disease. Ann Intern Med (1971) 1.12
Induction of -globin synthesis in the -thalassaemia of Ferrara. Nat New Biol (1972) 1.08
Topology and order of formation of interchain disulfide bonds in von Willebrand factor. Blood (1987) 1.08
Inducers of erythroid differentiation in K562 human leukemia cells. Exp Hematol (1981) 1.07
Erythroid colony formation from human fetal liver. Proc Natl Acad Sci U S A (1978) 1.06
The major 67 000 molecular weight protein of the clam oocyte nuclear envelope is lamin-like. J Cell Sci (1984) 1.04
Cystic fibrosis carrier population screening in the primary care setting. Am J Hum Genet (1996) 1.02
Prenatal hemoglobinopathy screening. IV. Follow-up of women at risk for a child with a clinically significant hemoglobinopathy. Am J Hum Genet (1991) 1.01
Newborn sickle cell screening. Benefits and burdens realized. Am J Dis Child (1983) 0.96
Opioid growth factor regulates the cell cycle of human neoplasias. Int J Oncol (2000) 0.95
Hemoglobin synthesis in cultures of hepatic erythroid cells from the human fetus. Proc Natl Acad Sci U S A (1979) 0.94
Genetic counseling of asymptomatic carriers in a primary care setting. The effectiveness of screening and counseling for beta-thalassemia trait. Ann Intern Med (1986) 0.94
Effect of cage population density on plasma corticosterone and peripheral lymphocyte populations of laboratory mice. Lab Anim (1989) 0.94
Family issues in a psychoeducation group for women with a BRCA mutation. Clin Genet (2002) 0.91
Monoclonal antibodies to human progesterone receptor: characterization by biochemical and immunohistochemical techniques. Endocrinology (1987) 0.91
Distinction between two types of beta-thalassaemia by inducibility of the cell-free synthesis of beta-chains by nonthalassaemic soluble fraction. Nat New Biol (1972) 0.89
Protein synthesis in the maturing reticulocyte. J Biol Chem (1967) 0.89
Separation of malarial parasites according to age by density gradient centrifugation. J Lab Clin Med (1967) 0.89
Multipotent human hematopoietic cell line K562: lineage-specific constitutive and inducible antigens. Leuk Res (1987) 0.88
Protein synthesis in reticulocytes maturing in vivo. Nature (1965) 0.86
Carrier screening for cystic fibrosis: test acceptance and one year follow-up. Am J Med Genet (1997) 0.86
Newborn screening for sicle-cell disease. Benefits and burdens. N Y State J Med (1978) 0.86
The neurofibroma in von Recklinghausen neurofibromatosis has a unicellular origin. Am J Hum Genet (1991) 0.86
Pathogenesis of deficient serum alpha1-antitrypsin in the type ZZ homozygote. Biochem Genet (1974) 0.85
An adult homozygous for persistent fetal hemoglobin. Ann Intern Med (1970) 0.85
Erythroleukemia manifesting delta beta-thalassemia. Hemoglobin (1983) 0.85
Alveolar cell carcinoma in identical twins. Similarity in time of onset, histochemistry, and site of metastasis. Ann Intern Med (1977) 0.85
Linkage between the MN- and Hb beta-loci? Hum Hered (1972) 0.84
Sickle hemoglobin: a specific radioimmunoassay. Blood (1974) 0.84
Toward providing parents the option of avoiding the birth of the first child with Cooley's anemia: response to hemoglobinopathy screening and counseling during pregnancy. Ann N Y Acad Sci (1985) 0.84
Regulation of K562 cell transferrin receptors by exogenous iron. J Cell Physiol (1985) 0.84
The diagnosis of beta-thalassemia trait: a review. Am J Hematol (1976) 0.84
A Lepore hemoglobin in a Rumanian family. Hum Hered (1969) 0.84
Incorporation of screening and genetic counseling for beta-thalassemia trait into primary health care: effects on knowledge and attitudes. Birth Defects Orig Artic Ser (1982) 0.83
Hemoglobin S-C disease presenting as acute cor pulmonale. Am Rev Respir Dis (1968) 0.83
Acquired hemoglobin H disease in idiopathic myelofibrosis. Am J Hematol (1979) 0.82
Detection of human immunodeficiency virus-infected lymphoid cells at low frequency by flow cytometry. J Immunol Methods (1987) 0.82
K562 human leukemia cell passages differ in embryonic globin gene expression. Leuk Res (1984) 0.81
Solubilization of a reticulocyte ribosomal fraction responsible for the decline in ribosomal activity with cell maturation. Arch Biochem Biophys (1971) 0.81
K562 human erythroleukemia cells demonstrate commitment. Blood (1985) 0.81
Kinetics of infected cell appearance as a determinant of number of human immunodeficiency virus-1 infectious units. AIDS Res Hum Retroviruses (1989) 0.80
DNA content is an independent prognostic indicator in endometrial adenocarcinoma. A Gynecologic Oncology Group study. Int J Gynecol Pathol (1998) 0.80
Predicting immediate outcome of genetic counseling following screening. Soc Biol (1979) 0.80
Oncogene expression in neurofibromatosis. Ann N Y Acad Sci (1986) 0.80
The linkage relationships of the haemoglobin beta, delta and alpha loci with 34 genetic marker systems. Ann Hum Genet (1977) 0.80
Single K562 human leukemia cells express and are inducible for both erythroid and megakaryocytic antigens. Int J Cell Cloning (1992) 0.80
Induction of megakaryocytic characteristics in human leukemic cell line K562: polyploidy, inducers, and secretion of mitogenic activity. J Biol Regul Homeost Agents (1988) 0.80
Hemin preferentially stimulates synthesis of alpha-globin in K562 human erythroleukemia cells. Blood (1982) 0.79
Human lymphocyte telomerase is genetically regulated. Genes Chromosomes Cancer (1998) 0.79
Modulation of HLA-DR expression in epithelial cells by interleukin 1 and estradiol-17 beta. J Clin Endocrinol Metab (1990) 0.79
Telomere-related components are coordinately synthesized during human T-lymphocyte activation. Leuk Res (1999) 0.79
High resolution analysis of hemoglobins: polyacrylamide isoelectric focusing. Biochem Med (1972) 0.79
Serm alpha-antitrypsin types: elastase inhibition versus trypsin inhibition. Hum Hered (1974) 0.78
Isolation of UV-sensitive clones from a haploid frog cell line. Somatic Cell Genet (1979) 0.78
Tumor suppressor genes and inherited predisposition to malignancy. Semin Oncol (1989) 0.78
Induction of HL60 cell differentiation by tiazofurin and its analogues: characterization and efficacy. Blood (1991) 0.77
Disappearance of ribosomes and polyribosomes during in vivo erythroid maturation. Nature (1967) 0.77
Serum antitrypsin synthesis by the isolated perfused rat liver. Proc Soc Exp Biol Med (1975) 0.77
Hereditary haemorrhagic telangiectasia: aggravation by oral contraceptives? Lancet (1970) 0.77
Demonstration of commitment by K562 human erythroleukemia cells. Prog Clin Biol Res (1985) 0.77
Sickle beta-thalassemia: identical twins differing in severity implicate nongenetic factors influencing course. Am J Hematol (1976) 0.76
Regulation of the activity of heme degradative enzymes in K562 erythroleukemic cells: induction by thymidine. Exp Hematol (1987) 0.76
Effects of cellular fixatives on human immunodeficiency virus production. Cytometry (1990) 0.76
Selective isolation of reversible cold sensitive variants from Chinese hamster ovary cell cultures. J Cell Physiol (1976) 0.75
Characteristics of the antitrypsin activity of human serum. J Clin Pathol (1973) 0.75
K562 human erythroleukemia cell variants resistant to growth inhibition by butyrate have deficient histone acetylation. Am J Hum Genet (1984) 0.75
Prenatal screening for hemoglobinopathies. Am J Hum Genet (1991) 0.75
Confusion about breast-cancer screening. N Engl J Med (1997) 0.75
Genetics for the cardiologist. Part I: mendelian inheritance. Mod Concepts Cardiovasc Dis (1978) 0.75
Single-cell analysis of the relationship among transferrin receptors, proliferation, and cell cycle phase in K562 cells. Cytometry (1985) 0.75
K562 cell erythroid differentiation: requirement for a factor in fetal bovine serum. Exp Hematol (1985) 0.75